Dan Roden

Researchers on the NCI Moonshot grant focused on hereditary cancers include (front row, from left) Natasha Celaya-Cobbs, LPN, Georgia Wiesner, MD, Sarah Bland, MPH, MBA, (back row, from left) Trent Rosenbloom, MD, Josh Peterson, MD, MPH, and Marc Beller, PMP, BA.
November 14, 2019

NCI ‘Moonshot’ grant to boost hereditary cancer identification

VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.

By Tom Wilemon
October 24, 2019

Article examines need for genotyping after stenting

Genotyping can improve outcomes in patients who require anti-platelet therapy following stent placement to open narrowed or blocked coronary arteries and prevent a heart attack.

By Bill Snyder
October 17, 2019

Peterson, Roden honored for translational medicine efforts

Josh Peterson, MD, MPH, and Dan Roden, MD, are among 10 leaders in clinical pharmacology and translational medicine recognized this week by the American Society for Clinical Pharmacology and Therapeutics.

By Bill Snyder
The study team included, from left, Douglas Johnson, MD, Dan Roden, MD, Javid Moslehi, MD, Joe-Elie Salem, MD, PhD, and Ali Manouchehri, MD.
September 25, 2019

Study identifies targeted therapy’s cardiac risks

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.

By Tom Wilemon
Sara Van Driest, MD, PhD, with Dan Roden, MD, who nominated her for the award from the American Society of Clinical Pharmacology and Therapeutics.
May 22, 2019

Van Driest lands young investigator award from the American Society for Clinical Pharmacology and Therapeutics

Sara Van Driest, MD, PhD, assistant professor of Pediatrics and Medicine, recently received the 2019 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics.

By Christina Echegaray
June 21, 2018

Roden’s circulatory diseases research honored

Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

By Bill Snyder
June 21, 2018

Roden’s circulatory diseases research honored

Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.
By Bill Snyder
June 14, 2018

VUMC joins research network to fight atrial fibrillation

Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications.
By Bill Snyder
April 5, 2018

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.
By Bill Snyder
March 5, 2018

Nine new endowed chair recipients honored

Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.
By VUMC News and Communications
January 25, 2018

Personalized drug prescribing program expands, upgrades

Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.
By Paul Govern
December 7, 2017

Vanderbilt researchers’ papers among those most cited

Eight current faculty members at Vanderbilt have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
By Bill Snyder
October 19, 2017

McGill University honors Roden’s research career

Dan Roden, M.D., Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center (VUMC), was named to receive the 2017 Medicine Alumni Global Lifetime Achievement Award by the Faculty of Medicine of his alma mater, McGill University.
By Doug Campbell
1 2 3 4 5